摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(p-methoxyphenyl)-5-(trifluoromethyl)hydantoin | 959694-72-5

中文名称
——
中文别名
——
英文名称
5-(p-methoxyphenyl)-5-(trifluoromethyl)hydantoin
英文别名
4-(4-methoxyphenyl)-4-trifluoromethylimidazolidine-2,5-dione;5-(4-methoxyphenyl)-5-(trifluoromethyl)imidazolidine-2,4-dione
5-(p-methoxyphenyl)-5-(trifluoromethyl)hydantoin化学式
CAS
959694-72-5
化学式
C11H9F3N2O3
mdl
——
分子量
274.199
InChiKey
IDLBZGKSEMDJHG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    5-(p-methoxyphenyl)-5-(trifluoromethyl)hydantoin 在 barium hydroxide octahydrate 、 硫酸ammonium hydroxide 作用下, 以 为溶剂, 反应 72.0h, 以60%的产率得到α-(p-methoxyphenyl)-α-trifluoromethylglycine
    参考文献:
    名称:
    Efficient preparation of enantiomerically pure α-aryl-α-trifluoromethylglycines via Auto Seeded Programmed Polythermic Preferential Crystallization of 5-aryl-5-trifluoromethylhydantoins
    摘要:
    Both pure enantiomers of alpha-phenyl- (or alpha-(p-methoxyphenyl))-alpha-trifluoromethyl-glycine and their corresponding methyl esters were obtained on a preparative scale using the following four-step sequence: the preparation of 5-aryl-5-trifluoromethylhydantoins by a Bucherer-Bergs reaction starting from trifluoromethyl aryl ketones, optical resolution by Auto Seeded Programmed Polythermic Preferential Crystallization (AS3PC), basic hydrolysis of the enantiopure hydantoins by means of aqueous barium hydroxide, and esterification of the amino acids with trimethylsilyldiazomethane. Hydantoins 5 and 6 were proven to crystallize as conglomerates using first second harmonic generation and then X-ray powder diffraction. The absolute stereochemistry of (+)-5-phenyl-5-trifluoromethylhydantoin 5b was established to be (S) by X-ray diffraction analysis on a single-crystal. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2010.11.029
  • 作为产物:
    描述:
    碳酸氢铵potassium cyanide2,2,2-三氟-4-甲氧基乙酰苯ammonium hydroxideα-苯乙胺 作用下, 以 乙醇 为溶剂, 反应 120.08h, 以65%的产率得到5-(p-methoxyphenyl)-5-(trifluoromethyl)hydantoin
    参考文献:
    名称:
    Efficient preparation of enantiomerically pure α-aryl-α-trifluoromethylglycines via Auto Seeded Programmed Polythermic Preferential Crystallization of 5-aryl-5-trifluoromethylhydantoins
    摘要:
    Both pure enantiomers of alpha-phenyl- (or alpha-(p-methoxyphenyl))-alpha-trifluoromethyl-glycine and their corresponding methyl esters were obtained on a preparative scale using the following four-step sequence: the preparation of 5-aryl-5-trifluoromethylhydantoins by a Bucherer-Bergs reaction starting from trifluoromethyl aryl ketones, optical resolution by Auto Seeded Programmed Polythermic Preferential Crystallization (AS3PC), basic hydrolysis of the enantiopure hydantoins by means of aqueous barium hydroxide, and esterification of the amino acids with trimethylsilyldiazomethane. Hydantoins 5 and 6 were proven to crystallize as conglomerates using first second harmonic generation and then X-ray powder diffraction. The absolute stereochemistry of (+)-5-phenyl-5-trifluoromethylhydantoin 5b was established to be (S) by X-ray diffraction analysis on a single-crystal. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2010.11.029
点击查看最新优质反应信息

文献信息

  • Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
    申请人:Nique Francois
    公开号:US20100063120A1
    公开(公告)日:2010-03-11
    Compounds of formula (I): wherein X is O or S, R 1 is acyl, aldehyde, cycloalkyl, an optionally substituted alkyl, alkenyl or alkynyl, R 2 is H. alkyl, hydroxyalkyl, haloalkyl, alkenyl, or alkynyl; substituted alkyl; alkylcarbonyl; R 3 and R 4 are H, halogen, alkyl, alkenyl, alkynyl, alkoxyl, alkylthio, hydroxyalkyl, haloalkyl, haloalkenyl, or haloalkynyl; or R 3 and R 4 form an, optionally aromatic or heterocyclic, optionally substituted ring, R 5 is H, halogen, trifluoromethyl, —CN, or —NO2; not all of R 3 , R 4 , and R 5 being H, R 6 and R 9 are H, halogen, OH; alkyl. hydroxyalkyl, alkoxyl, thioalkyl, haloalkyl, alkenyl, or alkynyl; R 7 and R 8 are H, halogen, OH, SH; alkoxyl or alkylthio optionally substituted by OH and/or halogen; one of R 7 and R 8 not being H or halogen; or one of R 7 and R 8 is a pharmaceutically acceptable ester or thioester grouping, or R 6 is C 1-3 -alkyl or, together with either R 1 or R 2 , represents C 1-3 alkylene or alkenylene linking group, optionally substituted by methyl, trifluoromethyl, OH, or halogen, and pharmaceutically acceptable salts and esters thereof, are useful as selective androgen modulators.
    式(I)的化合物:其中X为O或S,R1为酰基,醛基,环烷基,或可选择地取代的烷基,烯基或炔基,R2为H,烷基,羟基烷基,卤代烷基,烯基或炔基;取代烷基;烷基羰基;R3和R4为H,卤素,烷基,烯基,炔基,烷氧基,烷硫基,羟基烷基,卤代烷基,卤代烯基,或卤代炔基;或R3和R4形成一个,可选择的芳香或杂环,可选择地取代的环,R5为H,卤素,三氟甲基,-CN,或-NO2;R3,R4和R5中不全为H,R6和R9为H,卤素,羟基;烷基,羟基烷基,烷氧基,硫代烷基,卤代烷基,烯基,或炔基;R7和R8为H,卤素,羟基,硫氢基;烷氧基或烷硫基,可选择地由羟基和/或卤素取代;R7和R8中的一个不为H或卤素;或R7和R8中的一个为药用可接受的酯或硫酯基团,或R6为C1-3-烷基或,与R1或R2中的任一者一起,代表C1-3烷基或烯基链连接基,可选择地由甲基,三氟甲基,羟基,或卤素取代,以及其药用可接受的盐和酯,可用作选择性雄激素调节剂。
  • IMIDAZOLIDINE DERIVATIVES, USES THEREFOR, PREPARATION THEREOF AND COMPOSITIONS COMPRISING SUCH
    申请人:NIQUE Francois
    公开号:US20100210699A1
    公开(公告)日:2010-08-19
    Compounds of formula (I): wherein X is O or S, R 1 is acyl, aldehyde, cycloalkyl, an optionally substituted alkyl, alkenyl or alkynyl, R 2 is H, alkyl, hydroxyalkyl, haloalkyl, alkenyl, or alkynyl; substituted alkyl; alkylcarbonyl; R 3 and R 4 are H, halogen, alkyl, alkenyl, alkynyl, alkoxyl, alkylthio, hydroxyalkyl, haloalkyl, haloalkenyl, or haloalkynyl; or R 3 and R 4 form an, optionally aromatic or heterocyclic, optionally substituted ring, R 5 is H, halogen, trifluoromethyl, —CN, or —NO 2 ; not all of R 3 , R 4 , and R 5 being H, R 6 and R 9 are H, halogen, OH; alkyl, hydroxyalkyl, alkoxyl, thioalkyl, haloalkyl, alkenyl, or alkynyl; R 7 and R 8 are H, halogen, OH, SH; alkoxyl or alkylthio optionally substituted by OH and/or halogen; one of R 7 and R 8 not being H or halogen; or one of R 7 and R 8 is a pharmaceutically acceptable ester or thioester grouping, or R 6 is C 1-3 -alkyl or, together with either R 1 or R 2 , represents C 1-3 alkylene or alkenylene linking group, optionally substituted by methyl, trifluoromethyl, OH, or halogen, and pharmaceutically acceptable salts and esters thereof, are useful as selective androgen modulators.
    化合物式(I):其中X为O或S,R1为酰基,醛基,环烷基,可选取代的烷基,烯基或炔基,R2为H,烷基,羟基烷基,卤代烷基,烯基或炔基;取代烷基;烷基羰基;R3和R4为H,卤素,烷基,烯基,炔基,烷氧基,烷硫基,羟基烷基,卤代烷基,卤代烯基或卤代炔基;或R3和R4形成一个可选的芳香或杂环,可选取代的环,R5为H,卤素,三氟甲基,—CN或—NO2;R3,R4和R5不全为H,R6和R9为H,卤素,OH;烷基,羟基烷基,烷氧基,硫代烷基,卤代烷基,烯基或炔基;R7和R8为H,卤素,OH,SH;烷氧基或烷硫基,可选取代为OH和/或卤素;R7和R8中的一个不为H或卤素;或R7和R8中的一个是药物可接受的酯或硫酯基团,或R6为C1-3烷基或与R1或R2中的一个共同表示C1-3烷基或烯基链连接基团,可选取代为甲基,三氟甲基,OH或卤素,以及其药物可接受的盐和酯,用作选择性雄激素调节剂。
  • US8168667B2
    申请人:——
    公开号:US8168667B2
    公开(公告)日:2012-05-01
  • Efficient preparation of enantiomerically pure α-aryl-α-trifluoromethylglycines via Auto Seeded Programmed Polythermic Preferential Crystallization of 5-aryl-5-trifluoromethylhydantoins
    作者:Thibaut Martin、Cédrik Massif、Nicolas Wermester、Julie Linol、Séverine Tisse、Pascal Cardinael、Gérard Coquerel、Jean-Philippe Bouillon
    DOI:10.1016/j.tetasy.2010.11.029
    日期:2011.1
    Both pure enantiomers of alpha-phenyl- (or alpha-(p-methoxyphenyl))-alpha-trifluoromethyl-glycine and their corresponding methyl esters were obtained on a preparative scale using the following four-step sequence: the preparation of 5-aryl-5-trifluoromethylhydantoins by a Bucherer-Bergs reaction starting from trifluoromethyl aryl ketones, optical resolution by Auto Seeded Programmed Polythermic Preferential Crystallization (AS3PC), basic hydrolysis of the enantiopure hydantoins by means of aqueous barium hydroxide, and esterification of the amino acids with trimethylsilyldiazomethane. Hydantoins 5 and 6 were proven to crystallize as conglomerates using first second harmonic generation and then X-ray powder diffraction. The absolute stereochemistry of (+)-5-phenyl-5-trifluoromethylhydantoin 5b was established to be (S) by X-ray diffraction analysis on a single-crystal. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英